Evelyn Partners Investment Management LLP Bristol Myers Squibb CO Transaction History
Evelyn Partners Investment Management LLP
- $3.52 Trillion
- Q3 2025
A detailed history of Evelyn Partners Investment Management LLP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Evelyn Partners Investment Management LLP holds 5,339 shares of BMY stock, worth $249,064. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,339
Previous 7,344
27.3%
Holding current value
$249,064
Previous $282 Million
14.58%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.56BCall Options Held
24.3MPut Options Held
25.7M-
Vanguard Group Inc Valley Forge, PA196MShares$9.14 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.4 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.51 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.02 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.41 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.2B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...